RIPK2 and breast cancer: In fact, quantitative mass spectrometry-based proteomic and phosphoproteomic analyses of 105 breast cancer data have reported that RIPK2 has a similar gene amplification pattern to HER2 and that HER2 amplification showed an increase level of phosphoproteins [64].